Safe and effective medical management of pain for people with rheumatoid arthritis: Current evidence, patient perspectives, and person-centred deprescribing
Rheumatoid arthritis (RA) is a condition that causes joint inflammation and affects ∼19 million adults globally. Pharmacological management can include a combination of disease-modifying antirheumatic drugs (DMARDs) and pain medicines. Where the response to DMARDs has been good, pain medicines may n...
Saved in:
Main Authors: | Lisa Vizza, Sujita W. Narayan, Peter Youssef, Rowena Ivers, Matthew Youssef, Alexander Youssef, Rachel Thompson, Christina Abdel Shaheed |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Health Literacy and Communication Open |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/28355245.2025.2536504 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The US Deprescribing Research Network: a network to catalyze deprescribing science
by: Raha Shahroodi, et al.
Published: (2025-07-01) -
Deprescribing in psychiatry: challenges and opportunities
by: Zh. B. Bibekova, et al.
Published: (2020-09-01) -
<i>“Put Me in, Coach”</i>: A Discussion of Deprescribing Roles, Responsibilities, and Motivations Based on a Qualitative Study with Healthcare Professional Students
by: Devin Scott, et al.
Published: (2025-05-01) -
Development of artificial intelligence-assisted deprescribing chatbot for patients with cystic fibrosis discontinuing proton pump inhibitors
by: Kristin M. Zimmerman, et al.
Published: (2025-12-01) -
Deprescribing Antihypertensive Drugs in Patients of Older Age Groups
by: O. D. Ostroumova, et al.
Published: (2020-03-01)